"
Team:Peking R/HumanPractice/Investigation2
From 2011.igem.org
(Difference between revisions)
Grasscliff (Talk | contribs) |
Grasscliff (Talk | contribs) |
||
| Line 293: | Line 293: | ||
<th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | ||
<th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | <th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | ||
| - | <th width="18" bgcolor="# | + | <th width="18" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th> |
<th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | ||
<th width="45" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th> | <th width="45" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th> | ||
| Line 304: | Line 304: | ||
<th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | ||
<th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | <th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | ||
| - | <th width="16" bgcolor="# | + | <th width="16" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th> |
<th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | <th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | ||
<th width="44" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th> | <th width="44" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th> | ||
Revision as of 12:14, 20 September 2011
Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground
Investigation of Antibiotic Use and
Related Biosafety Issues: What's
happening out there and further.
Question 5
| A.Almost always discard directly or pour into sewage(15.91%) |
B.Usually discard directly and occasionally process them properly(22.73%) |
C.Usually process them properly but occasionally discard directly(21.59%) |
D.Always properly process them separately with other waste(23.86%) |
E.No special attention has been paid(15.91%) |
Question 6
Question 8
Question 9
